As the generic version of Lusutrombopag launched by Big Bear Pharmaceutical in Laos, LUTRODX provides a new treatment option for adult patients with chronic liver disease and thrombocytopenia who are planning to undergo surgery, with a once-daily oral dose of 3mg taken for 7 consecutive days.
How much does the Big Bear (Laos) generic Lusutrombopag cost?
The Big Bear (Laos) generic Lusutrombopag is available in a specification of 3mg*7 tablets per box, with a price of approximately $133. The actual price may be affected by various factors and should be based on the prevailing retail price.
Dosage and Administration of Lusutrombopag
Lusutrombopag is provided as 3mg oral tablets in child-resistant blister packaging, with 7 tablets per box. The recommended dosage and administration is: 3mg orally once daily for 7 consecutive days. Patients may take the tablet with or without food, as food does not affect drug absorption. The timing of Lusutrombopag administration must be precisely coordinated with the surgical plan – treatment should begin 8 to 14 days before the scheduled surgery, and the surgery should be performed 2 to 8 days after the last dose. This time window is designed to ensure sufficient time for the drug to stimulate platelet production, allowing platelet counts to reach optimal levels at the time of surgery. If a patient misses a dose, it should be taken as soon as possible on the same day, and the normal dosing schedule should be resumed the next day. Platelet counts should be monitored regularly during treatment, with at least one measurement on day 5 of dosing. Patients should strictly follow the instructions of their healthcare provider when taking Lusutrombopag, and should not adjust the dose or discontinue the drug without authorization. Before starting treatment, patients should inform their doctor of all medications they are taking, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements, to avoid potential drug interactions.
Storage Conditions and Patient Precautions for Lusutrombopag
The storage conditions for Lusutrombopag are relatively simple but must be strictly observed to ensure product quality. The drug should be stored at room temperature, specifically within the range of 68°F to 77°F (20°C to 25°C). The medication should always be kept in the original child-resistant blister packaging, protected from moisture and direct sunlight. Lusutrombopag and all medications should be kept out of the reach of children to prevent accidental ingestion. Before starting Lusutrombopag, patients should honestly inform their doctor of all medical conditions, especially including the following important information: whether they have a history of blood clots or thrombosis; whether they have any other coagulation abnormalities in addition to thrombocytopenia; whether they are pregnant or planning to become pregnant – Lusutrombopag may cause harm to the fetus; and whether they are breastfeeding or planning to breastfeed. As it is unknown whether Lusutrombopag passes into breast milk, it is recommended not to breastfeed during treatment and for at least 28 days after the last dose. Patients should fully communicate with their healthcare provider to discuss the optimal infant feeding method during Lusutrombopag treatment. If any suspected adverse reactions occur, patients should promptly report them to medical professionals.
